Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Intravesical solution |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Intravesical dose form (dose form) |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Powder for intravesical suspension |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Conventional release solution for intravesical and urethral irrigation (dose form) |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Powder for conventional release intravesical solution (dose form) |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Intravesical suspension |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Conventional release intravesical or parenteral or urethral solution |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
False |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Powder for conventional release intravesical or parenteral or urethral solution |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
False |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Concentrate for conventional release intravesical solution (dose form) |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Conventional release intravesical solution and solution for injection (dose form) |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|
Powder for conventional release intravesical solution and solution for injection (dose form) |
Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. |
True |
An intended site for a dose form that is for administration to the cavity of the urinary bladder. |
Inferred relationship |
Some |
|